glp-1 and chronic kidney disease Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes Safety of SGLT2i and RAs Combination therapy as a new

Effective pharmacotherapy combined with psychological support improves abstinence

Unlike statins, which can cause myopathy through effects on muscle cell membranes and mitochondrial function, GLP-1 agonists do not have a known direct myotoxic mechanism

The link between amino acids and thyroid health We have established that abundant amino acids are essential for a healthy thyroid, so where individuals may have diets low in protein, their thyroid health could be affected

y l s kt hp c khuyn khch

It is important to note that claims about increased energy expenditure in humans remain insufficiently evidenced at this stage, and the net glycaemic effects reflect observed trial outcomes rather than a straightforward mechanistic reduction in hepatic glucose output the concurrent glucagon receptor agonism may, in fact, influence hepatic glucose production in a complex and not fully characterised manner